Advertisement
United Laboratories International Holdings First Half 2025 Earnings: Misses Expectations
United Laboratories International Holdings (HKG:3933) First Half 2025 Results
Key Financial Results
- Revenue: CN¥7.52b (up 4.8% from 1H 2024).
- Net income: CN¥1.89b (up 27% from 1H 2024).
- Profit margin: 25% (up from 21% in 1H 2024). The increase in margin was primarily driven by higher revenue.
- EPS: CN¥1.04 (up from CN¥0.82 in 1H 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
United Laboratories International Holdings Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 5.1%. Earnings per share (EPS) also missed analyst estimates by 22%.
Looking ahead, revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in Hong Kong.
Performance of the Hong Kong Pharmaceuticals industry.
The company's share price is broadly unchanged from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 3 warning signs for United Laboratories International Holdings (1 is concerning) you should be aware of.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:3933
United Laboratories International Holdings
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
Very undervalued with excellent balance sheet.
Market Insights
Advertisement
Weekly Picks
ST
stuart_roberts on Upside Gold ·
An Undervalued 3.3Moz Gold Project in Canada
Fair Value:CA$5.0768.0% undervalued
284 followersusers have followed this narrative
1 commentusers have commented on this narrative
41 likesusers have liked this narrative
GO
GoldenSands on QuantumScape ·
QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality
Fair Value:US$8591.3% undervalued
92 followersusers have followed this narrative
1 commentusers have commented on this narrative
23 likesusers have liked this narrative
TO
Tokyo on Anheuser-Busch InBev ·
EU#8 - Anheuser-Busch InBev: Courage, Capital, and the Discipline to Build an Empire
Fair Value:€89.4524.2% undervalued
7 followersusers have followed this narrative
3 commentsusers have commented on this narrative
3 likesusers have liked this narrative
OS
oscargarcia on Amazon.com ·
The capitalist colossus that makes your parcels magically appear, powers half the internet, and knows your shopping habits.
Fair Value:US$2803.2% undervalued
62 followersusers have followed this narrative
1 commentusers have commented on this narrative
2 likesusers have liked this narrative
Recently Updated Narratives
TA
Talos on Evaxion ·
The "AI-Immunology" Asymmetric Opportunity – Validated by Merck (MSD)
Fair Value:US$20.2579.9% undervalued
3 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnonymousPlanner on Adobe ·
Good Value for a Creative Monopoly
Fair Value:US$317.6619.3% undervalued
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
CO
composite32 on Ronesans Gayrimenkul Yatirim ·
Investing in the future with RGYAS as fair value hits 228.23
Fair Value:₺313.4139.2% undervalued
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Popular Narratives
GO
GoldenSands on QuantumScape ·
QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality
Fair Value:US$8591.3% undervalued
92 followersusers have followed this narrative
1 commentusers have commented on this narrative
23 likesusers have liked this narrative
KI
Kingman1152 on NVIDIA ·
NVIDIA will see a profit margin surge of 55% in the next 5 years
Fair Value:US$305.230.7% undervalued
68 followersusers have followed this narrative
2 commentsusers have commented on this narrative
24 likesusers have liked this narrative
AN
AnalystConsensusTarget on Microsoft ·
Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks
Fair Value:US$561.9325.1% undervalued
1396 followersusers have followed this narrative
2 commentsusers have commented on this narrative
12 likesusers have liked this narrative
